首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs
【24h】

A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs

机译:萘醌-钴(III)原型生物还原性前药的性质和反应性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Our group has recently initiated a study on the development of newprototypes for bioreductive prodrugs, based on Co(III) complexes with the ligand 2,2′-bis(3-hydroxy-1,4-naphthoquinone), H_2bhnq. The focus of thiswork is to investigate the dissociation of bhnq~(?2) fromthe complex upon reduction, and the effects of pH, redox potential, oxygen concentration and nature of the auxiliary ligands on this reaction. The bhnq~(2?) ligand is a "non-cytotoxic" agent that was chosen as a probe for the reactivity studies due to its suitable chromophoric properties, at the same time that it resembles more cytotoxic naphthoquinones relevant for cancer therapy. In this way, two Co(III) complexes [Co(bhnq)(L1)]BF_4·H_2O (1) and [Co(bhnq)(L2)]BF_4·H_2O (2) (L1 = N,N′-bis(pyridin-2- ylmethyl)ethylenediamine and L2 = N,N′-dimethyl-N,N′-bis(pyridin-2-ylmethyl)ethylenediamine) were synthesized and fully characterized. The gallium analogs [Ga(bhnq)(L1)]NO_3·3H_2O (3) and [Ga(bhnq)(L2)] NO_3·3H_2O (4) were also prepared for helping with the assignments of the redox properties of the cobalt complexes and the structure of 2. Cyclic voltammetry analysis revealed a pH-independent quasi-reversible Co(III)/Co(II) process at ?0.22 and ?0.08 V vs NHE for 1 and 2, respectively. An O_2-dependent dissociation of bhnq~(2?) was observed for the reaction of 1 with ascorbic acid. For 2, the dissociation of bhnq~(2?) was found to be independent on the concentration of O_2 and faster than in 1,with little influence of the pH on both complexes. The difference in reactivity between 1 and 2 and their redox properties, among other factors, suggests that 1 undergoes redox cycling, pointed out as a key feature for a prodrug to achieve hypoxic selectivity.
机译:我们小组最近基于与配体2,2'-双(3-羟基-1,4-萘醌)H_2bhnq的Co(III)配合物,开始了生物还原性前药新原型开发的研究。这项工作的重点是研究还原后bhnq〜(?2)与配合物的离解,以及pH,氧化还原电势,氧浓度和辅助配体性质对该反应的影响。 bhnq-(2β)配体是一种“非细胞毒性”试剂,由于其合适的发色特性而被选作反应性研究的探针,同时它类似于与癌症治疗有关的更多的细胞毒性萘醌。这样,两个Co(III)络合物[Co(bhnq)(L1)] BF_4·H_2O(1)和[Co(bhnq)(L2)] BF_4·H_2O(2)(L1 = N,N'-bis合成并充分表征了(吡啶-2-基甲基)乙二胺和L2 = N,N′-二甲基-N,N′-双(吡啶-2-基甲基)乙二胺。还制备了镓类似物[Ga(bhnq)(L1)] NO_3·3H_2O(3)和[Ga(bhnq)(L2)] NO_3·3H_2O(4),以帮助分配钴配合物的氧化还原性质。以及2.的结构。循环伏安法分析表明,pH无关的准可逆Co(III)/ Co(II)过程在1和2下分别相对于NHE分别在0.22 V和0.08V。对于1与抗坏血酸的反应,观察到了bhnq〜(2α)的O_2依赖性解离。对于2,发现bhnq〜(2α)的解离与O_2的浓度无关,并且比1中的要快,而pH对两种配合物的影响都很小。在1和2之间的反应性差异以及它们的氧化还原特性以及其他因素表明,1经历了氧化还原循环,这是前药实现低氧选择性的关键特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号